close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BMY

Recent news which mentions BMY

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
Tickers BMY NEWS SYRS
Tags Pharmaceutical Health Care SYRS
From Benzinga
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
Tickers ABBV BMY NBIX NEWS
Tags News Equities Briefs
From Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Tickers ARGX BMY IFF IHRT
Tags BMY S Trading Ideas
From Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
Tickers ABBV BMY LLY NEWS
Tags Top Stories News BMY
From Benzinga
What's Going On With Bristol-Myers Squibb Shares Monday?
Tickers ABBV BMY NEWS
Tags ABBV Benzinga Market News
From Benzinga
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
Tickers ABBV BMY NEWS
Tags Trading Ideas Briefs BMY
From Benzinga
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
Tickers BMY EVO NEWS NVO
Tags Rumors Market News Benzinga
From Benzinga
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
Tickers ABBV BMY NEWS
Tags pharmaceuticals Market News Benzinga
From Benzinga
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Tickers AFRM BMY BTBT BTDR
Tags Mid/Day Movers Trading Ideas COIN
From Benzinga
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Tickers ABBV ALNY BMY GILD
Tags Large Cap ABBV General
From Benzinga
Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
Tickers BMY NEWS NVO TEVA
Tags Stories That Matter Health Care Guidance
From Benzinga
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
Tickers BMY MRK NEWS SMMT
Tags General Biotech SMMT
From Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
Tickers BMY
Tags Short Ideas BZI/SHORTHIST Trading Ideas
From Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
Tickers BMY NEWS
Tags Analyst Ratings Health Care Analyst Color
From Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Tickers AAPL AMGN AMZN BKNG
Tags UBER AAPL Economics
From Benzinga
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
Tickers BMY
Tags Recent Press Releases BMY Market News
From Motley Fool
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
Tickers BMY NEWS
Tags Health Care Stories That Matter Movers
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags Large Cap ABBV REGN
From Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
Tickers BMY GILD LYEL NEWS
Tags News Top Stories Briefs
From Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
Tickers BMY
Tags Benzinga Market News BMY
From Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
Tickers BMY IBRX MRK NEWS
Tags Stories That Matter Movers Initiation
From Benzinga
Why Is Evotec Stock Gaining Today?
Tickers BMY EVO NEWS
Tags Benzinga Market News Markets
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags Price Target Health Care Analyst Ratings
From Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Tickers BMY JNJ
Tags JNJ BMY Market News
From Motley Fool
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Tickers BMY CATX NEWS
Tags CATX Market News Benzinga
From Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
Tickers BMY NEWS RVPH
Tags Analyst Ratings Analyst Color Health Care
From Benzinga
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
Tickers BMY
Tags BMY Market News Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers BMY ELV HIMS HUM
Tags MRNA HUM HIMS
From Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
Tickers AAPL AI BMY GILD
Tags BMY MSFT NVDA
From Benzinga
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Tickers BMY CRM PFE
Tags Top Stories Trading Ideas PFE
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today